The recent federal government shutdown had a significant impact on scientific research efforts at the Wistar Institute, adding to the challenges faced by researchers in an already uncertain funding environment. With funding freezes, canceled grants, and the inability of the National Institutes of Health (NIH) to review grant proposals, the shutdown halted research progress across the country.
Wistar Institute President and CEO Dario Altieri expressed concerns about the institute’s future amidst ongoing funding precarity. While Wistar was not heavily affected by initial research cuts this year, the shutdown halted the review process for grant proposals, bringing research activities to a standstill.
As federal lawmakers renew budget talks, Altieri and other leaders in the scientific research community are advocating for increased funding for the NIH. The Pennsylvania Ad Hoc NIH Funding Advocacy Coalition, which includes institutions like the University of Pennsylvania and Children’s Hospital of Philadelphia, is urging lawmakers to allocate $47.2 billion to the NIH in the upcoming fiscal year, a $400 million increase from previous proposals.
In a bipartisan effort, the coalition is emphasizing the importance of NIH funding for the health and well-being of individuals in the Commonwealth. Altieri highlighted the need for predictability in funding sources, emphasizing the collaborative efforts of research institutions in Pennsylvania.
As the shutdown ends, the coalition continues to push for increased NIH funding, with hopes that lawmakers will prioritize the health and research needs of the community. The advocacy efforts of organizations like the American Association for Cancer Research and the Pennsylvania Biotechnology Center underscore the importance of sustained funding for biomedical research.
The collaborative spirit among research institutions in Pennsylvania serves as a model for lawmakers to work together across party lines. Altieri emphasized the importance of unity in advocating for NIH funding, echoing the sentiments of the broader biomedical research community.
The call for increased NIH funding comes at a critical time for scientific research, with ongoing challenges and uncertainties in funding streams. By rallying support for sustained funding, researchers aim to continue their vital work in advancing medical knowledge and finding cures for diseases.
As the scientific community navigates the complexities of funding and advocacy, the push for increased NIH funding remains a top priority for researchers and institutions dedicated to improving health outcomes and saving lives.
This article is a testament to the resilience and dedication of the scientific research community in the face of challenges, and the ongoing efforts to secure funding for critical research initiatives.
—
2025 The Philadelphia Inquirer. Distributed by Tribune Content Agency, LLC.
